Dr. Srisunder Subramaniam is the CEO of VentureStudio, Ahmedabad University. Dr. Subramaniam has more than 15 years of experience in the life science sector spanning research, product development, investment planning, business and operations strategy for diverse organizations ranging from global pharma and startups to academic medical centers and public health organizations. He was most recently a management consultant at PwC and worked extensively with diverse clients on vaccine development, genomics and personalized medicine. Prior to this, he was in a cancer diagnostic startup company, coordinating efforts for the development of an antibody for the immunohistochemistry market.
Dr. Subramaniam has a Ph.D. in Biophysics from The Ohio State University. As a postdoctoral scientist at Eli Lily & Company, he developed a tool kit of structural methods for faster, less expensive drug target molecular interaction analysis to enable faster understanding of structure-activity-relationships. He has received a master of Business Administration with concentrations in finance and entrepreneurship from the University of Chicago, Booth School of Business.